Prädiktive Diagnostik bei Chorea Huntington: Psychotherapeutische Aspekte der Beratung von Risikopersonen

Zusammenfassung

Der Fortschritt der molekulargenetischen Forschung ermöglicht zunehmend die prädiktive Diagnostik erblich bedingter Erkrankungen. Vor dem Hintergrund der Literatur werden die komplexen psychischen Aspekte prädiktiver Diagnostik ausgeführt und bestehende Beratungsansätze zusammengefasst. Trotz umfangreicher Studien sind die psychischen Reaktionen im Einzelfall schwer einzuschätzen. Wesentlich erscheint, genügend Zeit vor der Untersuchung zu gewinnen, um auch unbewusste Einflüsse auf Motivation und Bewältigungsstrategien berücksichtigen zu können. Auch nach der Ergebnismitteilung sollte den Betroffenen eine stützende Beratung angeboten werden.

Abstract

The progress in molecular genetic research leads to an increased availability of predictive diagnosis of inherited diseases. However, the prediction of an incurable illness is inevitably related with severe psychic conflicts. Based on the relevant literature, the psychological implications of predictive diagnostics are outlined, and counselling strategies for persons vulnerable for an inherited disease are summarized. In spite of numerous studies with persons at risk the prediction of the individual reaction remains rather difficult. Unconscious expectations play an essential, but underestimated role for the test motivation and coping strategies. Relieving the pressure of time supposed by most of the risk persons seems necessary to allow a deeper understanding of motivation and development of sound coping strategies. After disclosure of the test result, an ongoing counselling should be offered to all family members.

Literatur

• 1 Zühlke C, Thies U. Chorea Huntington: Molekulargenetische Grundlagen, Mutationsnachweis und prädiktive Diagnostik.  Nervenarzt. 1996;  67 25-35
• 2 Harper P S. Huntington Disease. London; WB Saunders Co 1996
• 3 Gusella J F, Wexler N S, Conneally P M. et al . A polymorphic DNA marker genetically linked to Huntington's disease.  Nature. 1983;  306 234-238
• 4 Huntingtons's Disease Collaborative Research Group . A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington' disease chromosomes.  Cell. 1993;  72 971-983
• 5 Tibben A, Niermeijer M F, Roos R AC. et al . Understanding the low uptake of presymptomatic DNA-testing for Huntington's disease.  Lancet. 1992;  340 1416
• 6 Laccone F, Engel U, Holonski-Feder E. et al . DNA analysis of Huntington's disease. Five years of experience in Germany, Austria, and Switzerland.  Neurology. 1999;  53 801-806
• 7 Hayden M R. Predictive testing for Huntington's disease: the calm after the storm.  Lancet. 2000;  356 1944-1945
• 8 Creighton S, Almquist E W, MacGregor D. et al . Predictive, prenatal and diagnostic genetic testing for Huntingtons' disease: the experience in Canada from 1987 to 2000.  Clin Genet. 2003;  63 462-475
• 9 Harper P S, Lim C, Craufurd D. Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.  J Med Genet. 2000;  37 567-571
• 10 Kessler S. Predictive Testing for Huntington's Disease: A Psychologist's View.  Am J MedGen. 1994;  54 161-166
• 11 Kreuz F R. Attitudes of german persons at risk for Huntington's Disease toward predictive and prenatal testing.  Genetic counselling. 1996;  7 303-311
• 12 Evers-Kiebooms G, Swerts A, Cassiman J J, Berghe H Van den. The motivation of at risk individuals and their partners in deciding for or against predictive testing for Huntington's disease.  Clin Genet. 1989;  54 174-184
• 13 Tibben A. Presymptomatic testing for Huntington's disease.  Am J Med Genet. 1993;  48 103-111
• 14 Codori A M, Hanson R, Brandt J. Self-selection in predictive testing for Huntington's disease.  Am J Med Genet. 1994;  54 167-173
• 15 Lazarus R S, Folkman S. Stress, appraisal, and coping. New York; Springer 1994
• 16 Copley T T, Wiggins S, Dufrasne S. et al . Are we all of one mind? Clinicians' and patients' opinions regarding the development of a service protocol for predictive testing for Huntington's disease.  Am J Med Genet. 1995;  58 59-69
• 17 Bloch M, Adam S, Fuller A. et al . Diagnosis of Huntington's disease: A model for the stages of psychological response based on experience of a predictive testing program.  Am J Med Genet. 1993;  47 368-374
• 18 Quaid K A. Presymptomatic testing for Huntington's disease: The U. S. experience.  Am J Hum Genet. 1993;  51 1063
• 19 Codori A M, Brandt J. Psychological costs and benefits of predictive testing for Huntington's disease.  Am J Med Genet. 1994;  54 174-184
• 20 Tibben A, Frets P G, Kamp J JP Van de. et al . On attitudes and appreciation 6 months after predictive DNA-testing for Huntington's disease in the Dutch program.  Am J Med Genet. 1993;  48 103-111
• 21 Huggins M, Bloch M, Wiggins S. et al . Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk.  Am J Med Genet. 1992;  42 508-515
• 22 Sobel K S, Cowan D B. Impact of genetic testing for Huntington disease on the family system.  Am J Med Gen. 2000;  90 49-59
• 23 Decruyenaere M, Evers-Kiebooms G, Cloostermans T, Boogaerts A, Demyttenaere K, Dom R, Fryns J P. Predictive testing for Huntingon's disease: relationship with partners after testing.  Clin Genet. 2004;  65 24-31
• 24 Wiggins S, Whyte P, Huggins M. et al . The psychological consequences of predictive testing for Huntingtons's disease.  New Engl J Med. 1992;  327 1401-1405
• 25 Hayden M R. Predictive testing in Huntington's disease. Are we ready for widespread community implementation?.  Am J Med Genet. 1991;  40 515-517
• 26 Lawson K, Wiggins S, Green T. et al . Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.  J Med Genet. 1996;  33 856-862
• 27 DudokdeWit A C, Tibben A, Duivenvoorden H J, Niermeijer M F, Passchier J. Distress in individuals facing predictive DNA testing for autosomal dominant late onset disorders: Comparing questionnaire results with in-depth interviews.  Am J Med Genetic. 1998;  75 62-74
• 28 Almquist E W, Bloch M, Brinkman R. et al . A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.  Am J Hum Genet. 1999;  64 1293-1304
• 29 Almquist E W, Brinkman R R, Wiggins S, Hayden R. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntingtons' disease.  Clin Genet. 2003;  64 300-309
• 30 Timman R, Roos R, Maat-Kievit A, Tibben A. Adverse effects of predictive testing for Huntington's disease underestimated: long-term effects 7 - 10 years after the test.  Health Psychol. 2004;  23 189-207
• 31 Evers-Kiebooms G. Predictive testing for Huntington's disease in Belgium.  J Psychosom Obstet Gynecol. 1990;  11 61-72
• 32 Decruyenaere M, Evers-Kiebooms G, Boogaerts A. et al . Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.  J Med Genet. 1996;  33 737-743
• 33 International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea . Guidelines for the molecular genetics predictive test in Huntington's disease.  Neurology. 1994;  44 1533-1536
• 34 Sharpe N F. Informed consent and Huntington's disease: A model for communication.  Am J Med Gen. 1994;  50 236-239
• 35 Meincke U, Kosinski C H, Zerres K, Maio G. Psychiatrische und ethische Aspekte genetischer Diagnostik am Beispiel Huntington.  Nervenarzt. 2003;  74 413-419
• 36 Müller A, Kreuz F R. Copingstrategien für die Huntingtonsche Krankheit.  Neurol Rehabil. 1998;  4 71-75
• 37 Laplanche J, Pontalis J-B. Das Vokabular der Psychoanalyse. Frankfurt a. M.; Suhrkamp 1972: 595-598
• 38 Beutel M. Zur Erforschung der Verarbeitung chronischer Krankheit: Konzeptualisierung, Operationalisierung und Adaptivität von Abwehrprozessen am Beispiel der Verleugnung.  Psychother med Psychol. 1985;  35 295-302
• 39 Steffens W, Kächele H. Abwehr und Bewältigung - Mechanismen und Strategien. In: Kächele H, Steffens W (Hrsg) Bewältigung und Abwehr. Beiträge zur Psychologie und Psychotherapie schwerer körperlicher Krankheiten. Berlin, Heidelberg; Springer 1988: 1-50
• 40 Richartz E, Frank C. Psychodynamisch orientierte Beratung im Rahmen prädiktiver Diagnostik bei Chorea Huntington.  Psychiat Prax. 2004;  31 255-258
• 41 Steenstraaten I M Van der, Tibben A, Roos R AC. et al . Predictive testing for Huntington's disease: Nonparticipants compared with participants in the Dutch program.  Am J Hum Genet. 1994;  55 618-625
• 42 Meissen G J, Mastromauro C A, Kiely D K. et al . Understanding the decision to take the predictive test for Huntington's disease.  Am J Med Genet. 1991;  39 404-410
• 43 Binedell J, Soldan J R. Nonparticipation in Huntington's Disease Predictive testing: reasons for caution in interpreting findings.  J of Genetic Counseling. 1997;  6 419-432
• 44 Speit D. Erfahrungen mit der psychotherapeutischen Begleitung vor prädiktiver DNA-Diagnostik.  Deutsche Huntington Hilfe. 1993;  93 7-11
• 45 Tassicker R J. Psychodynamic theory and counselling in predictive testing for Huntington's disease.  J Genet Couns. 2005;  14 99-107